Clin2
NCT02633553Possibly a fitRecruiting

Radiation after surgery for stage II or III thymoma

Thymoma

Part of Blood & lymphatic, Cancer clinical trials.

This trial looks at adding radiation after a complete surgery to remove a thymoma (a tumor from the thymus) at stages II or III. It may help lower the chance the cancer comes back by treating leftover microscopic disease after surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
238 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are 18 to 75 years old.
  • Your general health is good enough that you can do daily activities (performance status 0 to 2).
  • Your thymoma has been confirmed by pathology as stage II or III.
  • You had the tumor completely removed, and the surgery happened within the last 3 months.
  • Your blood counts and kidney and liver tests are within limits.
  • You have no distant spread of the cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07693855Not yet recruiting
Shorter radiation therapy after surgery for thymoma or thymic carcinoma

This trial tests a shorter course of radiation therapy (hypofractionated) given after surgery for thymoma or thymic carcinoma. The goal is to see if this approach is safe and effective for people with stage I to III disease who need radiation after their thymus gland was removed.

Taichung
NCT06730308Recruiting· Phase 2
Steroids with chemoradiation for thymoma that can't be removed

This trial tests if adding a steroid (methylprednisolone) to standard chemotherapy and radiation helps people with thymoma that cannot be fully removed by surgery or has come back. The goal is to see if this combination works better at controlling the disease.

Guanzhou, Guangdong
NCT06692062Recruiting
Hypofractionated radiation for thymoma and thymic carcinoma

This trial tests a shorter course of radiation (hypofractionated radiotherapy) for people with thymoma or thymic carcinoma. It aims to see if fewer, larger doses of radiation are safe and effective for treating these tumors.

Changsha, Hunan
NCT06924619Recruiting· Phase 2
Radiation before surgery for advanced thymoma

This trial tests giving radiation therapy before surgery for a type of thymus gland tumor (thymoma) that has grown into nearby tissues but has not been treated yet. The goal is to see if this approach can make the tumor removable and improve outcomes.

Hangzhou, Zhejiang
NCT06402708Recruiting· Phase 3
Chemotherapy after surgery for thymic cancer

This trial tests whether additional chemotherapy after surgery can help prevent thymic cancer from coming back. It is for people who have had their thymus tumor completely removed and are in good health.

Shanghai, Shanghai Municipality
NCT06311968Recruiting· Phase 2
Proton radiation after surgery for thymus tumors

This trial tests a type of precise radiation called proton therapy after surgery for thymus tumors. It may help reduce the chance of the tumor coming back while limiting side effects to nearby organs.

Shanghai, Shanghai Municipality

Hear when a new Thymoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.